다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
CNS Pharmaceuticals Inc (CNSP)
CNS Pharmaceuticals Inc (CNSP) 뉴스

CNSP

CNS Pharmaceuticals (CNSP)

CNS Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CNSP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/12	02:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/11/16	06:19	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/11/15	07:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/11/01	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/10/29	05:15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/10/25	06:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/10/25	00:23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/10/23	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/10/16	06:24	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/09/19	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/09/12	21:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/09/03	21:00	GlobeNewswire Inc.	IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/15	06:22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/07	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/07	06:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/07	05:53	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/05	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/03	05:11	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/08/01	01:32	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/31	06:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/31	06:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/30	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/26	21:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/26	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/24	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/20	06:12	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/13	05:30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/07/10	00:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/06/18	00:17	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CNSP	CNS Pharmaceuticals Inc
2024/06/15	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNSP	CNS Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:CNSP

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

JP Morgan Chase

American Express

Bank of America

Deutsche Telekom (QX)

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관